The following replaces the announcement "Result of Annual General Meeting and Directorate Change" released on 15 December 2023 at 14:07 under RNS No: 0306X.
Resolution 10 incorrectly stated : (i) 0 votes against- this has been corrected to 111; and (ii) total votes cast (excluding votes withheld) of 28,801,720- this has been corrected to 28,801,831.
Nothing else has been amended. The full corrected version is below.
RNS
AIM: FIPP
15 December 2023
Frontier IP Group Plc
("Frontier IP" or the "Group")
Result of Annual General Meeting and Directorate Change
Frontier IP, a specialist in commercialising intellectual property, announces that at its annual general meeting ("AGM"), held earlier today, all resolutions were duly passed with the table below summarising proxy votes received.
The Company also confirms, as announced on 31 October 2023, that Andrew Richmond has not sought re-election as a director at today's annual general meeting and has stepped down from his role as Chairman with effect from today.
Dame Julia King, Baroness Brown of Cambridge has assumed the role of Chair following conclusion of today's AGM.
| RESOLUTIONS | NO OF VOTES FOR | % OF VOTES CAST (EXCLUDING VOTES WITHELD) | NO OF VOTES AGAINST | % OF VOTES CAST (EXCLUDING VOTES WITHELD) | TOTAL VOTES CAST (EXCLUDING VOTES WITHHELD) | NO OF VOTES WITHHELD |
| ORDINARY | ||||||
| 1. To receive the audited consolidated financial statements of the Company and its subsidiaries for the year ended 30 June 2023, together with the reports of the Directors and the Auditor thereon. | 28,798,831 | 100% | 0 | 0% | 28,798,831 | 7,001 |
| 2. To approve the report of the Board to the members on directors' remuneration for the year ended 30 June 2023. | 24,016,521 | 83% | 4,761,258 | 17% | 28,777,779 | 28,053 |
| 3. To re-appoint Neil Crabb as a Director of the Company and, being eligible, is offering himself for reappointment. | 28,779,740 | 100% | 3,000 | 0% | 28,782,740 | 23,092 |
| 4. To re-appoint Jacqueline McKay as a Director of the Company and, being eligible, is offering herself for reappointment. | 28,779,740 | 100% | 0 | 0% | 28,779,740 | 26,092 |
| 5. To re-appoint James Fish as a Director of the Company and, being eligible, is offering himself for reappointment. | 28,779,740 | 100% | 0 | 0% | 28,779,740 | 26,092 |
| 6. To re-appoint Matthew White as a Director of the Company and, being eligible, is offering himself for reappointment. | 28,779,740 | 100% | 0 | 0% | 28,779,740 | 26,092 |
| 7. To re-appoint David Holbrook as a Director of the Company and, being eligible, is offering himself for reappointment. | 28,779,740 | 100% | 0 | 0% | 28,779,740 | 26,092 |
| 8. To re-appoint Nigel Grierson as a Director of the Company and, being eligible, is offering himself for reappointment | 28,779,740 | 100% | 0 | 0% | 28,779,740 | 26,092 |
| 9. To re-appoint Professor Dame Julia King, Baroness Brown of Cambridge as a Director of the Company and, being eligible, is offering herself for reappointment. | 28,779,740 | 100% | 0 | 0% | 28,779,740 | 26,092 |
| 10. To resolve not to fill the vacancy created by the retirement of Andrew Richmond as a Director and Chairman of the Company at the AGM, in accordance with the Articles of Association of the Company | 28,801,720 | 100% | 111 | 0% | 28,801,831 | 4,001 |
| 11. To re-appoint BDO LLP as auditor of the Company to hold office until the conclusion of the next general meeting at which financial statements are laid before shareholders. | 28,797,617 | 100% | 0 | 0% | 28,797,617 | 8,215 |
| 12 To authorise the Directors to determine the auditor's remuneration | 28,797,617 | 100% | 4,214 | 0% | 28,801,831 | 4,001 |
| 13. To authorise the directors to allot shares | 28,779,740 | 100% | 19,091 | 0% | 28,798,831 | 7,001 |
| SPECIAL | ||||||
| 14. Authority to disapply pre-emption rights in connection with the allotment and issue of equity securities for cash in relation to (i) share option schemes; (ii) rights issue or similar offer; (iii) allotment of equity securities up to 10% of the issued share capital; or (iv) to the allotment of equity securities up to a nominal amount equal to 20%, such authority to be used only for the purposes of making a follow-on offer which the Board of the Company determines to be of a kind contemplated by paragraph 3 of Section 2B of the Statement of Principles on Disapplying Pre-Emption Rights. | 23,213,401 | 81% | 5,585,430 | 19% | 28,798,831 | 7,001 |
| 15. Authority to disapply pre-emption rights to allot equity securities for cash. | 27,929,775 | 97% | 849,965 | 3% | 28,779,740 | 26,092 |
| 16. Authority to purchase own shares on market. | 24,461,860 | 100% | 7,850 | 0% | 24,469,710 | 4,336,122 |
Votes which have been cast at the discretion of the Chairman have been counted as votes for the resolutions. Votes Withheld are not votes in law and do not count in the number of votes counted for or against a resolution.
ENQUIRIES
| Frontier IP Group Plc Neil Crabb, Chief Executive
Andrew Johnson, Communications & Investor Relations Company website: www.frontierip.co.uk
| T: 020 3968 7815
M: 07464 546 025 andrew.johnson@frontierip.co.uk
|
| Allenby Capital Limited (Nominated Adviser) Nick Athanas / George Payne
| T: 0203 328 5656 |
| Singer Capital Markets (Broker) Harry Gooden / James Fischer | T: 0207 496 3000
|
ABOUT FRONTIER IP
Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services. A critical part of the Group's work is involving relevant industry partners at an early stage of development to ensure technology meets real world demands and needs.
The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
